Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.230
-0.050 (-2.19%)
At close: Apr 28, 2026, 4:00 PM EDT
2.150
-0.080 (-3.59%)
After-hours: Apr 28, 2026, 6:13 PM EDT
CELZ Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.01 | 0.01 | 0.01 | 0.09 | 0.09 | |
| Revenue Growth (YoY) | -45.45% | 22.22% | -89.84% | 0.96% | -46.65% | |
| Cost of Revenue | 0 | 0 | 0 | 0.03 | 0.05 | |
| Gross Profit | 0 | 0.01 | 0.01 | 0.06 | 0.04 | |
| Selling, General & Admin | 3.76 | 3.24 | 3.56 | 3.94 | 2.96 | |
| Research & Development | 2.26 | 2.4 | 1.97 | 6.27 | 0.11 | |
| Amortization of Goodwill & Intangibles | 0.12 | 0.11 | 0.09 | 0.09 | 0.09 | |
| Operating Expenses | 6.15 | 5.75 | 5.63 | 10.3 | 3.17 | |
| Operating Income | -6.14 | -5.74 | -5.62 | -10.24 | -3.13 | |
| Interest Expense | - | - | - | - | -4.28 | |
| Interest & Investment Income | 0.15 | 0.25 | 0.33 | 0.1 | - | |
| Other Non Operating Income (Expenses) | - | - | - | - | 26.03 | |
| EBT Excluding Unusual Items | -6 | -5.49 | -5.29 | -10.14 | 18.63 | |
| Other Unusual Items | - | - | - | - | 0.59 | |
| Pretax Income | -6 | -5.49 | -5.29 | -10.14 | 19.21 | |
| Net Income | -6 | -5.49 | -5.29 | -10.14 | 19.21 | |
| Net Income to Common | -6 | -5.49 | -5.29 | -10.14 | 19.21 | |
| Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 0 | |
| Shares Change (YoY) | 60.95% | 5.17% | 28.76% | 236.51% | 460.63% | |
| EPS (Basic) | -2.52 | -3.71 | -3.76 | -9.28 | 73.75 | |
| EPS (Diluted) | -2.52 | -3.71 | -3.76 | -9.28 | 56.10 | |
| Gross Margin | 63.43% | 60.00% | 60.00% | 67.84% | 45.36% | |
| Operating Margin | -102380.23% | -52216.92% | -62445.91% | -11562.50% | -3562.17% | |
| Profit Margin | -99916.80% | -49940.74% | -58739.71% | -11449.26% | 21892.76% | |
| EBITDA | -6.02 | -5.63 | -5.53 | -10.15 | -3.03 | |
| D&A For EBITDA | 0.12 | 0.11 | 0.09 | 0.09 | 0.09 | |
| EBIT | -6.14 | -5.74 | -5.62 | -10.24 | -3.13 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.